IP Library Granted Patent US 11,035,002
Granted Patent B2
US 11,035,002 · App. 16/998,425 · Granted Jun 15, 2021

Methods and systems for processing polynucleotides

Inventors: Benjamin Hindson (Pleasanton, CA); Christopher Hindson (Pleasanton, CA); Michael Schnall-Levin (Palo Alto, CA); Kevin Ness (Pleasanton, CA); Mirna Jarosz (Mountain View, CA); Serge Saxonov (Oakland, CA); Paul Hardenbol (San Francisco, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6874C12Q1/6806C12Q1/6855C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,035,002
App. No.
16/998,425
Granted
Jun 15, 2021
Kind
B2
Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

Claims (47)

1. A method for nucleic acid processing, comprising:

(a) providing a partition comprising a nucleic acid molecule and a bead, wherein said bead comprises a barcode oligonucleotide molecule that is coupled to said bead through a photo-labile linkage, and wherein said barcode oligonucleotide molecule comprises a barcode sequence;

(b) applying a photo-stimulus to release said barcode oligonucleotide molecule from said bead, which photo-stimulus cleaves said photo-labile linkage; and

(c) using (i) said nucleic acid molecule and (ii) said barcode oligonucleotide molecule released from said bead to generate a barcoded nucleic acid molecule, wherein said barcoded nucleic acid molecule comprises said barcode sequence or complement thereof.

2. The method of claim 1 , wherein said barcode oligonucleotide molecule comprises a primer sequence.

3. The method of claim 2 , wherein said barcode oligonucleotide molecule hybridizes to said nucleic acid molecule via said primer sequence.

4. The method of claim 1 , wherein said nucleic acid molecule is derived from a sample nucleic acid molecule.

5. The method of claim 4 , further comprising, performing a nucleic acid extension reaction using said sample nucleic acid molecule to generate said nucleic acid molecule.

6. The method of claim 1 , wherein (a) further comprises providing one or more primers in said partition.

7. The method of claim 6 , wherein (c) comprises using said one or more primers to generate said barcoded nucleic acid molecule in said partition.

8. The method of claim 1 , wherein (c) comprises performing a nucleic acid extension reaction on said nucleic acid molecule or derivative thereof to generate said barcoded nucleic acid molecule.

9. The method of claim 1 , further comprising, providing a lysate from a single cell.

10. The method of claim 9 , wherein said single cell is a cancer cell, a cell derived from a solid tumor, a cell derived from a hematological malignancy, or a circulating tumor cell.

11. The method of claim 9 , wherein said lysate comprises a sample nucleic acid molecule.

12. The method of claim 11 , wherein said nucleic acid molecule is generated from said sample nucleic acid molecule.

13. The method of claim 1 , wherein said nucleic acid molecule comprises genomic deoxyribonucleic acid (gDNA) or is generated from gDNA.

14. The method of claim 1 , wherein, in (a), said partition is a partition among a plurality of partitions.

15. The method of claim 1 , wherein said partition is a microwell.

16. The method of claim 1 , wherein said partition is a droplet.

17. The method of claim 1 , wherein said partition comprises a lysate from a single cell.

18. The method of claim 17 , wherein said single cell is a cancer cell, a cell derived from a solid tumor, a cell derived from a hematological malignancy, or a circulating tumor cell.

19. The method of claim 17 , wherein said lysate comprises a sample nucleic acid molecule.

20. The method of claim 19 , wherein said nucleic acid molecule is generated from said sample nucleic acid molecule.

21. The method of claim 1 , wherein said partition comprises a set of primer pairs for amplifying gDNA.

22. The method of claim 14 , wherein said barcode sequence identifies said partition from another partition of said plurality of partitions.

23. The method of claim 1 , further comprising removing said barcoded nucleic acid molecule or a derivative thereof from said partition.

24. The method of claim 23 , wherein said partition is a droplet in an emulsion, and wherein said removing comprises breaking said emulsion.

25. The method of claim 1 , further comprising amplifying said barcoded nucleic acid molecule or a derivative thereof to provide a plurality of amplified barcoded nucleic acid molecules.

26. The method of claim 1 , further comprising attaching a functional sequence to said barcoded nucleic acid molecule or a derivative thereof.

27. The method of claim 26 , wherein said functional sequence is a sequencing primer or a sample index sequence.

28. The method of claim 1 , wherein said barcoded nucleic acid molecule or a derivative thereof is sequenced.

29. The method of claim 1 , wherein said bead comprises a plurality of barcode oligonucleotide molecules, which plurality of barcode oligonucleotide molecules comprises said barcode oligonucleotide molecule.

30. The method of claim 29 , wherein an additional barcode oligonucleotide molecule of said plurality of barcode oligonucleotide molecules comprises a primer sequence.

31. The method of claim 1 , wherein said partition further comprises nucleic acid extension reagents.

32. The method of claim 1 , wherein (b) occurs prior to (c).

33. The method of claim 1 , wherein said partition comprises a nuclease inactivating agent.

34. The method of claim 33 , wherein said nuclease inactivating agent is proteinase K.

35. The method of claim 2 , wherein said bead comprises an additional barcode oligonucleotide molecule comprising an additional primer sequence.

36. The method of claim 35 , wherein said primer sequence or said additional primer sequence is a targeted primer sequence.

37. The method of claim 23 , wherein said barcoded nucleic acid molecule or derivative thereof is sequenced.

38. The method of claim 25 , wherein said amplified barcoded nucleic acid molecules or derivatives thereof are sequenced.

39. The method of claim 14 , wherein said barcode sequence is unique to said partition of said plurality of partitions.

40. The method of claim 14 , further comprising pooling said barcoded nucleic acid molecule or derivative thereof from said partition with other barcoded nucleic acid molecules or derivatives thereof from other partitions of said plurality of partitions.

41. The method of claim 1 , wherein said nucleic acid molecule comprises ribonucleic acid (RNA).

42. The method of claim 1 , wherein said nucleic acid molecule is derived from RNA.

43. The method of claim 1 , wherein said barcode oligonucleotide molecule comprises a poly-T sequence.

44. The method of claim 43 , wherein said barcode oligonucleotide molecule hybridizes to said nucleic acid molecule via said poly-T sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2020
From: HINDSON, BENJAMIN; HINDSON, CHRISTOPHER; SCHNALL-LEVIN, MICHAEL; NESS, KEVIN; JAROSZ, MIRNA; SAXONOV, SERGE; HARDENBOL, PAUL; BHARADWAJ, RAJIV; ZHENG, XINYING; BELGRADER, PHILLIP
To: 10X GENOMICS, INC.
Reel/Frame 054112/0667 →
Continuity (37)
Continuation 16435417 · Jun 7, 2019
Continuation 16294769 · Mar 6, 2019
Continuation 16231185 · Dec 21, 2018
Continuation 16212441 · Dec 6, 2018
Continuation 16052431 · Aug 1, 2018
Continuation In Part 16000803 · Jun 5, 2018
Continuation 15850241 · Dec 21, 2017
Continuation 15588519 · May 5, 2017
Continuation 15376582 · Dec 12, 2016
Continuation In Part 14104650 · Dec 12, 2013
Continuation In Part 14250701 · Apr 11, 2014
Continuation 14175973 · Feb 7, 2014
Continuation In Part 15598898 · May 18, 2017
Continuation 14624468 · Feb 17, 2015
Division 13966150 · Aug 13, 2013
Continuation In Part 15847752 · Dec 19, 2017
Continuation 15717871 · Sep 27, 2017
Continuation In Part 14752641 · Jun 26, 2015
Continuation In Part 16052486 · Aug 1, 2018
Continuation In Part 16000803 · Jun 5, 2018
Continuation In Part 14316447 · Jun 26, 2014
Continuation In Part 13966150 · Aug 13, 2013
Continuation In Part PCTUS2013054797 · Aug 13, 2013
Provisional Application 61737374 · Dec 14, 2012
Provisional Application 61844804 · Jul 10, 2013
Provisional Application 61840403 · Jun 27, 2013
Provisional Application 61800223 · Mar 15, 2013
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 62061567 · Oct 8, 2014
Provisional Application 62017558 · Jun 26, 2014
Provisional Application 61683192 · Aug 14, 2012
Provisional Application 61896060 · Oct 26, 2013
Provisional Application 61909974 · Nov 27, 2013
Provisional Application 61991018 · May 9, 2014
Provisional Application 61940318 · Feb 14, 2014
Provisional Application 61937344 · Feb 7, 2014
Related Publication 20200385805A1 · Dec 10, 2020
Cited By (1)
US 12,312,640